Abstract
dc:description.abstractArtificial Intelligence (AI) has transformed health care with improved predictions, diagnostics, and treatments by using advanced analytics and models on data. In cancer, especially breast cancer treatment, clinical trials are an essential resource. Yet, very few people from diverse backgrounds have been included in these studies, which can lead to biases against underrepresented groups in health innovations. This thesis explores demo- graphic disparities in breast cancer clinical trials across the United States by analyzing representation patterns and what that means for equity in clinical research. Findings emphasize the need for inclusive trial designs and robust data collection with the aim of guiding equitable and e↵ective treatment development. I also point out that, while achieving equitable representation in clinical trials would be a great improvement, it is still not enough to support machine-learning classifiers used in diagnosis and genetic analysis, which generally require equal numbers of cases in training data for each class.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Data Science
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Alaoeasheg, Maya
- Advisor dc:contributor.advisor
-
- Wildman, Wesley J.
Subjects
dc:subject × 6Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-ShareAlike 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/49680